Skip to main content
SpringerLink
Log in

Findings of fluorine-18-FDG PET in extranodal origin lymphoma —In three cases of diffuse large B cell type lymphoma—

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

F-l 8 fluorodeoxyglucose (FDG) positron emission tomography (PET) is an excellent modality for non-invasive functional imaging of malignant lymphoma and is highly sensitive and specific for the detection of lymphoma lesions. Here, we report the findings of FDG-PET for three cases of diffuse large B cell type lymphoma (DLBCL) with extranodal tumors in the breast, stomach, and liver plus spleen, respectively. The whole body FDG-PET findings showed no evidence of lymph node (LN) involvement or distant metastasis. Strong FDG accumulations were observed in the only extranodal sites by whole body FDG-PET. Therefore, we could confirm that these cases were extranodal primary origins. Whole body PET is useful to determine the primary sites, that is, extranodal origin DLBCL with its clear images.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, et al. Prognostic Value of Positron Emission Tomography (PET) with Fluorine-18 Fluorodeoxyglucose ([18F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Is [18F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?J Clin Oncol 2001; 19: 414–419.

    PubMed  CAS  Google Scholar 

  2. Dizendorf EV, Baumert BG, von Schulthess GK, Lutolf UM, Steinert HC. Impact of Whole-Body18F-FDG PET on Staging and Managing Patients for Radiation Therapy.J Nucl Med 2003; 44: 24–29.

    PubMed  Google Scholar 

  3. Friedberg JW, Chengazi V. PET scans in the staging of lymphoma: current status.Oncologist 2003; 8: 438–447.

    Article  PubMed  Google Scholar 

  4. Metser U, Goor O, Lerman H, Naparstek E, Even-Sapir E. PET-CT of extranodal lymphoma.AJR 2004; 182: 1579–1586.

    PubMed  Google Scholar 

  5. Moog F, Bangerter M, Diederichs CG, Guhlmann A, Merkle E, Frickhofen N, et al. Extranodal malignant lymphoma: detection with FDG PET versus CT.Radiology 1998; 206: 475–481.

    PubMed  CAS  Google Scholar 

  6. Bar-Shalom R, Yefremov N, Haim N, Dann EJ, Epelbaum R, Keidar Z, et al. Camera-based FDG PET and67Ga SPECT in evaluation of lymphoma: comparative study.Radiology 2003; 227: 353–360.

    Article  PubMed  Google Scholar 

  7. Schaefer NG, Hany TF, Taverna C, Seifert B, Stumpe KD, von Schulthess GK, et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging—do we need contrast-enhanced CT?Radiology 2004; 232: 823–829.

    Article  PubMed  Google Scholar 

  8. Metser U, Miller E, Kessler A, Lerman H, Lievshitz G, Oren R, et al. Solid splenic masses: evaluation with18F-FDG PET/CT.J Nucl Med 2005; 46: 52–59.

    PubMed  Google Scholar 

  9. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin’s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas.Ann Oncol 1997; 8: 727–737.

    Article  PubMed  CAS  Google Scholar 

  10. Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F. Primary extranodal non-Hodgkin’s lymphomas. Part 2: Head and neck, central nervous system and other less common sites.Ann Oncol 1999; 10: 1023–1033.

    Article  PubMed  CAS  Google Scholar 

  11. Zucca E, Cavalli F. Extranodal lymphomas.Ann Oncol 2000; 11:219–222.

    Article  PubMed  Google Scholar 

  12. Lopez-Guillermo A, Colomo L, Jimenez M, Bosch F, Villamor N, Arenillas L, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.J Clin Oncol 2005; 23: 2797–2804.

    Article  PubMed  Google Scholar 

  13. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A Predictive Model for Aggressive Non-Hodgkin’ s Lymphoma.N Engl J Med 1993; 329: 987–994.

    Article  Google Scholar 

  14. Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi YE, et al. Intensity of18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes between Indolent and Aggressive Non-Hodgkin’s Lymphoma.J Clin Oncol 2005; 23: 4643–4651.

    Article  PubMed  Google Scholar 

  15. The Non-Hodgkin’s Lymphoma Classification Project. A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin’s Lymphoma.Blood 1997; 89: 3909–3918.

    Google Scholar 

  16. Ziarkiewicz-Wroblewska B, Gornicka B, Suleiman W, Wroblewski T, Morton M, Wilczynski GM, et al. Primary lymphoma of the liver—morphological and clinical analysis of 6 cases. Success of aggressive treatment.Neoplasma 2005; 52: 267–272.

    PubMed  CAS  Google Scholar 

  17. Noronha V, Shaft NQ, Obando JA, Kummar S. Primary non-Hodgkin’s lymphoma of the liver.Crit Rev Oncol Hematol 2005; 53: 199–207.

    Article  PubMed  Google Scholar 

  18. Sandrasegaran K, Robinson PJ, Selby P. Staging of lymphoma in adults.Clin Radiol 1994; 49: 149–161.

    Article  PubMed  CAS  Google Scholar 

  19. Bangerter M, Moog F, Griesshammer M, Merkle E, Hafner M, Ellenrieder V, et al. Usefulness of FDG-PET in diagnosing primary lymphoma of the liver.Int J Hematol 1997; 6: 517–520.

    Article  Google Scholar 

  20. Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin’s lymphomas of the female breast.Cancer 1992; 69: 725–735.

    Article  PubMed  CAS  Google Scholar 

  21. Vignot S, Ledoussal V, Nodiot P, Bourguignat A, Janvier M, Mounier N, et al. Non-Hodgkin’s Lymphoma of the Breast: A Report of 19 Cases and a Review of the Literature.Clin Lymphoma 2005; 6: 37–42.

    Article  PubMed  Google Scholar 

  22. Topalovski M, Crisan D, Mattson JC. Lymphoma of the breast. A clinicopathologic study of primary and secondary cases.Arch Pathol Lab Med 1999; 123: 1208–1218.

    PubMed  CAS  Google Scholar 

  23. Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP. Lymphomas of the breast: primary and secondary involvement.Cancer 2002; 94: 6–13.

    Article  PubMed  Google Scholar 

  24. Bakheet SM, Bakheet R, Ezzat A, Tulbah A, Durakovic A, Hussain S. F-18 FDG positron emission tomography in primary breast non-Hodgkin’s lymphoma.Clin Nucl Med 2001;26:299–301.

    Article  PubMed  CAS  Google Scholar 

  25. Kumar R, Xiu Y, Dhurairaj T, Yu JQ, Alavi A, Zhuang H. F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast.Clin Nucl Med 2005; 30:246–248.

    Article  PubMed  Google Scholar 

  26. Kumar R, Xiu Y, Potenta S, Mavi A, Zhuang H, Yu JQ, et al.18F-FDG PET for Evaluation of the Treatment Response in Patients with Gastrointestinal Tract Lymphomas.J Nucl Med 2004; 45: 1796–1803.

    PubMed  Google Scholar 

  27. d’Amore F, Brincker H, Gronbaek K, Thorling K, Pedersen M, Jensen MK. Non-Hodgkin’s lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.J Clin Oncol 1994; 12: 1673–1684.

    PubMed  CAS  Google Scholar 

  28. Cogliatti SB, Schmid U, Schumacher U, Eckert F, Hansmann ML, Hedderich J, et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients.Gastroenterology 1991; 101: 1159–1170.

    PubMed  CAS  Google Scholar 

  29. Fleming ID, Turk PS, Murphy SB, Crist WM, Santana VM, Rao BN. Surgical implications of primary gastrointestinal lymphoma of childhood.Arch Surg 1990; 125: 252–256.

    PubMed  CAS  Google Scholar 

  30. AJCC cancer staging manual. Sixth Edition. Springer, 2001 : 393–403.

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, National Center for Geriatrics and Gerontology, 36-3, Gengo, 474-8522, Morioka-cho, Ohbu, JAPAN

    Takashi Nihashi, Kazumasa Hayasaka, Rikio Kato & Kengo Ito

  2. Department of Hematology, National Center for Geriatrics and Gerontology, JAPAN

    Toshihide Itou & Kengo Ito

  3. Department of Brain Science and Molecular Imaging, National Institute for Longevity Sciences, JAPAN

    Toshiharu Okae

  4. Department of Radiology, Anjo General Hospital, JAPAN

    Takeo Ishigaki

Authors
  1. Takashi Nihashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazumasa Hayasaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rikio Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toshihide Itou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kengo Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toshiharu Okae
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takeo Ishigaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Nihashi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nihashi, T., Hayasaka, K., Kato, R. et al. Findings of fluorine-18-FDG PET in extranodal origin lymphoma —In three cases of diffuse large B cell type lymphoma—. Ann Nucl Med 20, 689–693 (2006). https://doi.org/10.1007/BF02984681

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02984681

Key words

Search

Navigation